John F. Crowley - Oct 11, 2021 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
Director
Signature
/s/James Basta, Attorney-In-Fact
Stock symbol
NTLA
Transactions as of
Oct 11, 2021
Transactions value $
-$251,800
Form type
4
Date filed
10/13/2021, 04:15 PM
Previous filing
Oct 7, 2021
Next filing
Oct 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Options Exercise $47.1K +2.5K +119.39% $18.83 4.59K Oct 11, 2021 Direct
transaction NTLA Common Stock Sale -$299K -2.5K -54.42% $119.55 2.09K Oct 11, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTLA Stock Option (right to buy) Options Exercise $0 -2.5K -8.93% $0.00 25.5K Oct 11, 2021 Common Stock 2.5K $18.83 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 12,666 shares as of October 11, 2021.